![Stuart Poulton](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Stuart Poulton
Företagsledare/Principal på
KARYOPHARM THERAPEUTICS INC.
Förmögenhet: 862 871 $ per 2026-05-31
Profil
Stuart Poulton is Chief Development Officer & Executive VP at Karyopharm Therapeutics, Inc. since 2022.
Formerly, Mr. Poulton was Vice President-Clinical Development Operations at AbbVie, Inc. from 2019 to 2022, Executive Director-Global Program Management at Amgen, Inc. from 2013 to 2016, and Head-Clinical Operations at Eli Lilly & Co. Education includes graduate studies at The University of New South Wales and undergraduate studies at The University of Sydney.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-05-14 | 94 821 ( 0,42 % ) | 862 871 $ | 2026-05-31 |
Aktiva positioner av Stuart Poulton
| Företag | Position | Start |
|---|---|---|
| KARYOPHARM THERAPEUTICS INC. | Företagsledare/Principal | 2022-02-01 |
Tidigare kända positioner av Stuart Poulton
| Företag | Position | Slut |
|---|---|---|
| ABBVIE INC. | Företagsledare/Principal | 2022-01-01 |
| AMGEN INC. | Företagsledare/Principal | 2016-01-01 |
| ELI LILLY AND COMPANY | Teknisk/Vetenskaplig/F&U Direktör | - |
Stuart Poultons utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
73
Första gradens relationer
6
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 6 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Eli Lilly & Co.
 Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
AbbVie, Inc.
 AbbVie, Inc. Pharmaceuticals: MajorHealth Technology Engages in the research and development, manufacturing, commercialization & sale of immunology medicines and therapies | Health Technology |
The University of New South Wales
 The University of New South Wales Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Sydney
 The University of Sydney Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Karyopharm Therapeutics, Inc.
 Karyopharm Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel drugs for the treatment of cancer, inflammation and other diseases related to cell proliferation | Health Technology |
